SCHEMBL17359778

SCHEMBL17359778

CCCCO[C@H](C(=O)COC(c1ccccc1)(c1ccccc1)c1ccccc1)[C@@H](F)CO

nearest known ligand 0.36

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
PLA2G2A P14555 2/20 0.36
PLA2G10 O15496 1/20 0.36
PLA2G1B P04054 1/20 0.36
PLA2G5 P39877 1/20 0.36
GPR88 Q9GZN0 2/20 0.35
PTGDR2 Q9Y5Y4 1/20 0.34
HDAC6 Q9UBN7 2/20 0.34
TSHR P16473 4/20 0.33
TDP1 Q9NUW8 2/20 0.33
L3MBTL1 Q9Y468 2/20 0.33
KIF11 P52732 2/20 0.33
PLA2G4B P0C869 1/20 0.33
PPARD Q03181 1/20 0.32
POLB P06746 1/20 0.32
RECQL P46063 1/20 0.32
ALDH1A1 P00352 1/20 0.32
CYP3A4 P08684 1/20 0.32
MAPK1 P28482 1/20 0.32
TP53 P04637 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17359590 0.85 PLA2G2A (0.40) PLA2G2APLA2G10PLA2G1BPLA2G5KIF11
SCHEMBL17359609 0.73 PLA2G2A (0.33) PLA2G2APLA2G10PLA2G1BPLA2G5GPR88
SCHEMBL18609340 0.72 PLA2G2A (0.49) PLA2G2APLA2G10PLA2G1BPLA2G5KIF11
SCHEMBL15895042 0.69 PLA2G2A (0.40) PLA2G2APLA2G10PLA2G1BPLA2G5GPR88
SCHEMBL17359776 0.69 PLA2G2A (0.39) PLA2G2APLA2G10PLA2G1BPLA2G5KIF11
SCHEMBL3398385 0.69 KIF11 (0.59) TSHRTDP1L3MBTL1KIF11
SCHEMBL18912718 0.69 PLA2G2A (0.55) PLA2G2APLA2G10PLA2G1BPLA2G5HDAC6
SCHEMBL8353837 0.68 PLA2G2A (0.53) PLA2G2APLA2G10PLA2G1BPLA2G5ALDH1A1
SCHEMBL8195323 0.68 PLA2G2A (0.53) PLA2G2APLA2G10PLA2G1BPLA2G5ALDH1A1
SCHEMBL8356181 0.68 PLA2G2A (0.53) PLA2G2APLA2G10PLA2G1BPLA2G5ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150366887-A1 SUBSTITUTED NUCLEOSIDES, NUCLEOTIDES AND ANALOGS THEREOF Janssen Pharmaceuticals, Inc. 2015-12-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150366887-A1 SUBSTITUTED NUCLEOSIDES, NUCLEOTIDES AND ANALOGS THEREOF PNP, NUDT1, NT5C3B PLA2G2A 2939/4885PLA2G10 2487/4885PLA2G1B 2210/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.